8:33 PM
 | 
Aug 16, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Infectious company Aridis raises $26M in NASDAQ IPO

Infectious disease mAb company Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) raised $26 million on Aug. 13 through the sale of 2 million shares at $13 in an IPO on NASDAQ. Cantor Fitzgerald, Maxim Group, Laidlaw, Northland Securities and Seaport Global Securities underwrote the offering. The price is at the bottom of the $13-$15 range the company proposed on...

Read the full 260 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >